| Dr Joseph Broderick, DO | |
|
651 Dunlop Ln, Clarksville, TN 37040-5015 | |
| (931) 502-1300 | |
| Not Available |
| Full Name | Dr Joseph Broderick |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 651 Dunlop Ln, Clarksville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750812731 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101023253 (Michigan) | Secondary |
| 207P00000X | Emergency Medicine | 4018 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tennova Healthcare-shelbyville | Shelbyville, TN | Hospital |
| Vanderbilt University Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
InSite Vision Incorporated today announced that patient enrollment has been completed in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.
Peripheral or central nerve injury often leads to neuropathic pain, a chronic condition that can manifest behaviorally as spontaneous pain, hyperalgesia and allodynia, and which also results in neurological dysfunction.
Recent years have seen an unprecedented growth in number and availability of new synthetic psychoactive drugs in the US and worldwide. In 2014, 101 new psychoactive drugs were identified, worldwide. Such drugs are often sold as "legal" highs or "research chemicals" over the internet or in head shops. Among these new drugs, "bath salts" appear to be one of the more commonly used in the US.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today provided an update on the status of its New Drug Submission ("NDS") with Health Canada for Vitaros®, the Company's topical treatment for erectile dysfunction.
The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain hemorrhages. This is the conclusion of most extensive study ever carried out, which thus also rebuffs suspicions of the opposite being true.
› Verified 9 days ago
| Entity Name | App Of Tennessee Ed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003230236 PECOS PAC ID: 8123251766 Enrollment ID: O20140506000159 |
News Archive
InSite Vision Incorporated today announced that patient enrollment has been completed in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.
Peripheral or central nerve injury often leads to neuropathic pain, a chronic condition that can manifest behaviorally as spontaneous pain, hyperalgesia and allodynia, and which also results in neurological dysfunction.
Recent years have seen an unprecedented growth in number and availability of new synthetic psychoactive drugs in the US and worldwide. In 2014, 101 new psychoactive drugs were identified, worldwide. Such drugs are often sold as "legal" highs or "research chemicals" over the internet or in head shops. Among these new drugs, "bath salts" appear to be one of the more commonly used in the US.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today provided an update on the status of its New Drug Submission ("NDS") with Health Canada for Vitaros®, the Company's topical treatment for erectile dysfunction.
The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain hemorrhages. This is the conclusion of most extensive study ever carried out, which thus also rebuffs suspicions of the opposite being true.
› Verified 9 days ago
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
InSite Vision Incorporated today announced that patient enrollment has been completed in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.
Peripheral or central nerve injury often leads to neuropathic pain, a chronic condition that can manifest behaviorally as spontaneous pain, hyperalgesia and allodynia, and which also results in neurological dysfunction.
Recent years have seen an unprecedented growth in number and availability of new synthetic psychoactive drugs in the US and worldwide. In 2014, 101 new psychoactive drugs were identified, worldwide. Such drugs are often sold as "legal" highs or "research chemicals" over the internet or in head shops. Among these new drugs, "bath salts" appear to be one of the more commonly used in the US.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today provided an update on the status of its New Drug Submission ("NDS") with Health Canada for Vitaros®, the Company's topical treatment for erectile dysfunction.
The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain hemorrhages. This is the conclusion of most extensive study ever carried out, which thus also rebuffs suspicions of the opposite being true.
› Verified 9 days ago
| Entity Name | Emergency Medicine Services Of Tn, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720785884 PECOS PAC ID: 3173989837 Enrollment ID: O20230523000265 |
News Archive
InSite Vision Incorporated today announced that patient enrollment has been completed in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.
Peripheral or central nerve injury often leads to neuropathic pain, a chronic condition that can manifest behaviorally as spontaneous pain, hyperalgesia and allodynia, and which also results in neurological dysfunction.
Recent years have seen an unprecedented growth in number and availability of new synthetic psychoactive drugs in the US and worldwide. In 2014, 101 new psychoactive drugs were identified, worldwide. Such drugs are often sold as "legal" highs or "research chemicals" over the internet or in head shops. Among these new drugs, "bath salts" appear to be one of the more commonly used in the US.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today provided an update on the status of its New Drug Submission ("NDS") with Health Canada for Vitaros®, the Company's topical treatment for erectile dysfunction.
The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain hemorrhages. This is the conclusion of most extensive study ever carried out, which thus also rebuffs suspicions of the opposite being true.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Broderick, DO 4913 Illinois Ave, Nashville, TN 37209-2105 Ph: (248) 755-2513 | Dr Joseph Broderick, DO 651 Dunlop Ln, Clarksville, TN 37040-5015 Ph: (931) 502-1300 |
News Archive
InSite Vision Incorporated today announced that patient enrollment has been completed in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.
Peripheral or central nerve injury often leads to neuropathic pain, a chronic condition that can manifest behaviorally as spontaneous pain, hyperalgesia and allodynia, and which also results in neurological dysfunction.
Recent years have seen an unprecedented growth in number and availability of new synthetic psychoactive drugs in the US and worldwide. In 2014, 101 new psychoactive drugs were identified, worldwide. Such drugs are often sold as "legal" highs or "research chemicals" over the internet or in head shops. Among these new drugs, "bath salts" appear to be one of the more commonly used in the US.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today provided an update on the status of its New Drug Submission ("NDS") with Health Canada for Vitaros®, the Company's topical treatment for erectile dysfunction.
The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain hemorrhages. This is the conclusion of most extensive study ever carried out, which thus also rebuffs suspicions of the opposite being true.
› Verified 9 days ago
John D Shields, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1771 Madison St, Clarksville, TN 37043 Phone: 931-552-6622 | |
Dr. Malcolm A Steele, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 651 Dunlop Ln, Clarksville, TN 37040 Phone: 931-502-1370 | |
Manickam Krishnamurthy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Ln, Clarksville, TN 37040 Phone: 931-502-1370 | |
Mark A Muiznieks, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Lane Clarksville, Clarksville, TN 37040 Phone: 931-502-1370 | |
Dr. Russell Paul Landry Iii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Lane, Clarksville, TN 37040 Phone: 713-430-6095 | |
Dr. Timothy L Obernuefemann, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2320 Wilma Rudolph Blvd, Clarksville, TN 37040 Phone: 931-645-1564 Fax: 931-645-3842 | |
Dr. James Willis Hickerson Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Ln, Clarksville, TN 37040 Phone: 931-502-1370 |